NeuroPace NPCE
NASDAQ NPCE
$13.76 -0.18 (-1.29%)
At close: Sep 30, 2026 · 4:00 PM EDT

NeuroPace (NPCE) Short term Debt (2020 - 2021)

Updated

NeuroPace's Short term Debt was $3.59 million in Q1 2021, up 75.7% from the prior quarter.

Analysis

NeuroPace (NPCE) Short term Debt (2020 - 2021) Analysis & Trends

At the end of FY2020, Short term Debt at NeuroPace came in at $2.04 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 NeuroPace 477.90 Mn 251.15 Mn 18.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 3.59 Mn
Dec 31, 2020 2.04 Mn
API Access

NeuroPace Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=NPCE&period=max&api_key=YOUR_API_KEY